The application of a DNA nanobiosensor based on MXene/MWCNTs/PPY nanocomposite as a sensitive detection method of CEACAM5 for diagnosis of epithelial ovarian cancer-Reference-Cited by-同舟云学术

The application of a DNA nanobiosensor based on MXene/MWCNTs/PPY nanocomposite as a sensitive detection method of CEACAM5 for diagnosis of epithelial ovarian cancer

Published:2023-10 Issue: Volume:193 Page:109016
ISSN:0026-265X
Container-title:Microchemical Journal
language:en
Short-container-title:Microchemical Journal

Author:

Rajaie Sara,Nasiri Mahboobeh,Pasdar Alireza,Rezayi Majid,Khazaei Majid,hatamluyi Behnaz

Publisher

Elsevier BV

Subject

Spectroscopy,Analytical Chemistry

Reference46 articles.

1. Gynecologic cancer disparities: a report from the health disparities taskforce of the society of gynecologic oncology;Collins;Gynecol. Oncol.,2014

2. Epithelial ovarian cancer;Lheureux;Lancet,2019

3. Epidemiology of ovarian cancer: a review;Reid;Cancer Biol. Med.,2017

4. Discovery and validation of novel biomarkers for detection of epithelial ovarian cancer;Kulbe;Cells,2019

5. Clinical analysis of four serum tumor markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors;Chen;Cancer Manag. Res.,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing biocompatibility and functionality: Carbon nanotube-polymer nanocomposites for improved biomedical applications;Journal of Drug Delivery Science and Technology;2024-09

2. Construction of scalable multi-channel DNA nanoplatform for the combined detection of ctDNA biomarkers of ovarian cancer;Microchimica Acta;2024-08-21

3. A robust bioplatform based on DNA-gated nanoscale porous carbon derived from a metal-organic framework for specific detection of Herpes simplex virus type 1;Sensors and Actuators B: Chemical;2024-07

4. Construction of scalable multi-channel DNA nanoplatform for the combined detection of multi-component biomarkers of cancer;2024-06-25

5. Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment;Frontiers in Drug Delivery;2024-02-01